Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing: To date, the FDA has approved 36 cell and gene therapy products

Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing: To date, the FDA has approved 36 cell and gene therapy products

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biopharm international 2024-07, Vol.37 (7), p.14
Hauptverfasser: Cashen, Paul, Deckers, Susanne, Ladi, Rukmini
Format: Magazinearticle
Sprache:eng
Schlagworte:
Antigens
Cancer
Care and treatment
Cellular therapy
Drug approval
Evaluation
Gene therapy
Genes
Immunotherapy
Production management
T cells
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1542-166X